July 7, 2016 |
Drug maker Merck said that it will acquire a controlling interest in Vallée S.A., a private producer of animal health products in Brazil. Under the terms, Merck's animal health business in Madison, N.J. will acquire 93 percent of Vallée for $400 million, based on current exchange rates. The agreement is subject to regulatory review. Under the deal, Vallée's portfolio of more than 100 products including parasiticides, anti-infectives and vaccines for livestock, horses, and companion animals, will be combined with Merck's animal-health division.
June 7, 2013 |
Have some presummer fun as the Ninth Annual Sugar Cane Festival, hosted by Asociación Puertorriqueños en Marcha and cosponsored by Peco, returns on Saturday with a day of information and activities on Fifth Street between Berks and Norris Streets. The day will offer community presentations, face painting, animals from the Philadelphia Zoo, and more. Performances include the Kensington CAPA (Creative and Performing Arts) Drum Corps, Fuego Dance Company, urban pop duo Domino Saints, and singer Franco Olivo.
January 31, 2013 |
Pfizer Inc. chief executive officer Ian Read said Tuesday that the world's largest seller of pharmaceutical products will keep examining whether to one day separate the management of its "innovative" drugs from "established" drugs, with patents that have expired. Since digesting the $69 billion acquisition of Wyeth in 2009, Pfizer has been trying to get the most it can from its business operations while negating the loss of revenue from blockbuster drugs such as Lipitor, which now has generic competition.
June 9, 2012 |
Pfizer Inc. said Thursday that it would spin off its animal health unit and call the stand-alone company Zoetis. However, Pfizer will maintain control, so it was unclear how independent the new entity will be or how the differentiation will help Pfizer overall. Pfizer is based in Manhattan and has a big human pharmaceutical operation in Collegeville. The animal health unit has about 9,000 employees, with slightly more than 100 of them in Exton. Pfizer is preparing to file paperwork with the U.S. Securities and Exchange Commission for a potential stock offering in Zoetis, though the shares would represent a minority stake in the new company.
August 26, 2011 |
Who loves puppies more? Merck or Pfizer? Both global pharmaceutical giants have animal-health divisions, but they are considering different paths. Merck Inc. just announced that it was bringing a Philly guy home - sort of - to run its animal kingdom, and chief executive officer Ken Frazier (another Philly guy) highlighted the unit's results in his opening statement to investment analysts when discussing second-quarter results. Pfizer Inc. said it was exploring the sale or spin-off of its animal unit and its human-nutrition division.
July 7, 2011 |
NEW YORK - Pfizer Inc. said Thursday it may sell its animal health and nutrition business in the next two years so it can focus on expanding its low-cost pharmaceuticals unit. Pfizer, which has faced pressure to eliminate some business units and return more cash to shareholders, said the moves will allow investors to get more value for the businesses. The company will also consider transactions including spinoffs and may pursue different strategies for each business. Any transactions could take one to two years to complete, Pfizer said.
July 2, 2011
City School District and arithmetic Michael Masch, the CFO for the School District of Philadelphia, did a nice job of subterfuge in laying out the district's case for more funding ("Philly School District's spending under control," Tuesday). His analysis never even hints at one very glaring statistic: $2.7 billion. That's the budget for the district, down from $3.2 billion a few years ago. Deducting the funding for charter schools leaves $2.2 billion. With 25 percent of students now attending charters, that leaves approximately 120,000 other students left to educate.
May 26, 2011
A new flare-up in Sudan dispute JUBA, Sudan - Gunmen from an ethnic Arab tribe allied with the Sudanese government of President Omar al-Bashir fired on four U.N. peacekeeping helicopters taking off from a disputed border town at the heart of a new north-south conflict, officials said Wednesday. None of the helicopters was hit. Both Sudan's north and south claim Abyei, in a fertile region that has oil fields. The dispute has complicated the planned creation in July of a new nation out of southern Sudan after the settlement of a long civil war. The black African Ngok Dinka tribe, allied with the south, and the Arab Misseriya, allies of the north, both claim the area, which was taken over by northern troops and tanks Saturday after an attack on a northern convoy earlier.
March 22, 2011 |
PARIS - Drugmakers Merck & Co. and Sanofi-Aventis SA on Tuesday abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles. Merck and Sanofi-Aventis say they've agreed that keeping their animal health businesses separate is in the best interests of the companies, their shareholders and their employees. "The companies are discontinuing their agreement primarily because of the increasing complexity of implementing the proposed transaction, both in terms of the nature and extent of the anticipated divestitures and the length of time necessary for the worldwide regulatory review process," the companies said in a joint statement.
July 19, 2009 |
He's fat, neurotic, and unwittingly proffers his body as a romantic hideaway for vermin. And you love him so much that you spend hundreds or thousands of dollars yearly paying for pills, vaccines, and other products to keep him healthy. If this describes your relationship with your dog, you and your wallet know exactly why analysts expect companies bidding for the animal-health businesses of Pfizer Inc. and Merck & Co. Inc. to act like a pack of retrievers in hot pursuit of a drool-covered tennis ball: The market for these medicines is bounding.